Superior Pain And Itch Relief
Product Images NDC 69804-071

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Superior Pain And Itch Relief (NDC 69804-071). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ridge Properties Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
This text is a set of directions for using a product. It recommends testing the skin for sensitivity before using the product and discontinuing use if sensitivity occurs. It suggests applying thick, even layers of the product every 3-5 minutes until the desired level of pain relief is achieved. The text warns against using the product near the eyes.*
FDA Label Image

Inactive Ingredients (Inactive Ingredients Section)

FDA Label Image

Indications And Usage (Indications And Usage)

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)
This is a warning message for a product cautioning to keep it out of reach of children. The product is meant for use around the eyes and in case of ingestion, medical help or poison control should be contacted immediately.*
FDA Label Image

Active Ingredient (Otc Active Ingredient)

FDA Label Image

Purpose (Purpose)

Purpose (Purpose)
Purpose: Topical Anesthetic.*
FDA Label Image

Warnings Section (Warnings Section)

Warnings Section (Warnings Section)
Warning: KEEP OUT OF REACH OF CHILDREN. FOR EXTERNAL USE ONLY. NOT FOR USE AROUND THE EYES. IF INGESTED SEEK MEDICAL HELP OR CALL A POISON CONTROL CENTER IMMEDIATELY. Stop use and ask a doctor if skin becomes irritated, condition worsens, symptoms last longer than 7 days or if symptoms clear up and then return.*
FDA Label Image

Principal Display Panel (Principal Display Panel)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.